- Citations, last 5 years
- 356.5k
- Works, last 5 years
- 25.4k
- h-index
- 1,797
- Scientists listed
- 655
- Grants since 2016
- 3 144
Grants received
2021–2023 · research · R01
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
Kai W Wucherpfennig · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2023 · research · R21
Chemical manipulation of creatine kinases to treat acute myeloid leukemia
Edward Thomas Chouchani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
Matthew L Freedman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Statistical methods for cancer mutational signatures
Giovanni Luigi Parmigiani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · research · R01
Serologic and Molecular Studies of human anti-hCoV antibody cross-immunity and protective responses among endemic HCoVs and SARS-CoV2
Wayne A. Marasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · grant · D43
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA
Timothy R Rebbeck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2027 · career development · K00
Elucidating the Mechanisms of Translational Approaches to Enhance Recovery of Aged Muscle
Jonathan Joseph Petrocelli · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · career development · K08
The Impact of Donor Hematopoietic DNMT3A Mutations in Stem Cell Transplant Recipients
Christopher James Gibson · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021 · training · Postdoctoral Fellowships
Improving the representation of microbial reference genomes using pangenome reference sequence graphs - Methods for efficient construction and representation of pangenome graphs for microbial data
Justin Chu · Dana-Farber Cancer Institute · funded by Natural Sciences and Engineering Research Council of Canada
2021–2025 · grant · Continuing Grant
Advancing Statistical Methods for Multi-Study Predictions
Giovanni Parmigiani · Dana-Farber Cancer Institute · funded by National Science Foundation
2021–2026 · research · R01
A Stakeholder Informed Randomized Trial of Pretest Video Education vs Standard Genetic Counseling for Cancer Patients: Evaluating the Impact on Patients, Providers and Practices
Huma Q Rana · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2022 · career development · K08
Advancing WRN as a synthetic lethal target for microsatellite unstable Cancers
Edmond Chan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
CDK4/6 inhibition during CD8 T cell priming potentiates memory formation in mice and humans
Stephanie Dougan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2022 · cooperative agreement · UM1
XPO1 inhibitors Selinexor and Eltanexor in Combination with Venetoclax and Decitabine (ASTX727) in AML
Keith T Flaherty · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · fellowship · F32
Lipid metabolism as a therapeutic vulnerability in BET inhibitor-resistant medulloblastoma
Leslie Lupien · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2022 · career development · K08
Role of PPM1D and PPM1D mutations in hematopoiesis and response to stress
Peter Grant Miller · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · grant · KCRP
Utilizing Cell-Free Methylomes to Inform Clinical Scenarios in Renal Cell Carcinoma
Matthew Freedman · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021–2024 · research · R01
Determining mechanisms of the succinate thermogenesis pathways on UCP1-dependent and UCP1-independent thermogenesis
Edward Thomas Chouchani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021 · fellowship · Pew Biomedical Scholars Program
Edward Chouchani — Pew Biomedical Scholar (2021)
Edward Chouchani · Dana-Farber Cancer Institute · funded by Pew Charitable Trusts
2021–2025 · award
Epigenetic mechanisms of tumorigenesis
Bradley Bernstein · Dana-Farber Cancer Institute · funded by American Cancer Society
2021–2025 · research · R01
Scaling up tobacco control in India: Comparing smartphone to in-person training for implementing an evidence-based intervention to reduce tobacco use among schoolteachers
Eve M Nagler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021 · grant · LCRF-AstraZeneca Research Grant
2021 – LCRF-AstraZeneca Research Grant – Dana-Farber Cancer Institute – Lior Golomb, PhD
Lior Golomb · Dana-Farber Cancer Institute · funded by Lung Cancer Research Foundation
2021–2026 · research · R01
Elucidation of the genetic mechanisms driving prostate tumorigenesis through integrative computational and functional approaches
Matthew L Freedman · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · career development · K08
Characterizing the XRN1 exoribonuclease as a therapeutic target in non-small cell lung cancer
Tao Zou · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
Ruben D Carrasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021 · grant · LCRF-AstraZeneca Research Grant
2021 – LCRF-AstraZeneca Research Grant – Dana-Farber Cancer Institute – Antja-Voy Hartley
Antja-Voy Hartley · Dana-Farber Cancer Institute · funded by Lung Cancer Research Foundation
2021–2026 · research · R01
CDK4/6 inhibition during CD8 T cell priming potentiates memory formation in mice and humans
Stephanie Dougan · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2024 · career development · K99
Translational regulation of PGC1alpha and oxidative metabolism
Phillip Anthony Dumesic · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · grant · D43
BIDIRECTIONAL TRAINING TO ENHANCE CANCER RESEARCH CAPACITY IN AFRICA
Timothy R Rebbeck · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · grant · PCRP
Addressing Health Literacy with a Tailored Survivorship Care Plan to Improve Access in Underserved African American Prostate Cancer Patients
Kerry Kilbridge · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021–2026 · cooperative agreement · U01
Identification of Metabolic and Immune Deficits in the Aged Population and Their Restoration to Achieve Youthful Anti-Influenza Vaccine Responsiveness
Wayne A. Marasco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2023 · grant · DMDRP
Irisin and Therapeutics for Duchenne Muscular Dystrophy
Bruce Spiegelman · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021–2024 · research · R03
A Preventive Care Approach to Mitigate the Impact of Pediatric ALL Treatment on Sleep
Kira O. Bona · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · career development · K08
Investigating Transcriptional Elongation and Nuclear RNA Surveillance in Melanoma
Megan Leigh Insco · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R01
Statistical methods for cancer mutational signatures
Giovanni Luigi Parmigiani · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2025 · research · R01
Scaling up tobacco control in India: Comparing smartphone to in-person training for implementing an evidence-based intervention to reduce tobacco use among schoolteachers
Eve M Nagler · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · career development · K08
Elucidating the impact of DNA hypomethylation on genome organization and anti-tumor transcriptional programs
Sarah E Johnstone · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2026 · research · R35
Notice of Special Interest - R35 (Undergraduate Summer Funding)
Amy Si-Ying Lee · Dana-Farber Cancer Institute · funded by National Institutes of Health
2021–2023 · grant · KCRP
Selective Metabolic Dependencies in Kidney Cancer with Mitochondrial Mutations
Pere Puigserver · Dana-Farber Cancer Institute · funded by Congressionally Directed Medical Research Programs
2021 · career development · K99
Structural Basis for Small Molecule-Mediated Allosteric Activation of Protein Phosphatase 2A
Ken Morita · Dana-Farber Cancer Institute · funded by National Institutes of Health
